| Name | Title | Contact Details |
|---|
Theragenics Corporation is a medical device company serving the surgical products and cancer treatment markets. The Company operates in two segments: brachytherapy seed business and the surgical products business. In the brachytherapy seed business, the
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
AllTech Medical Systems is a Cleveland, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Scimega Research Inc is a Laval, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Gateway Community Services Medical Clinic is a East Lansing, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.